These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 10607699)

  • 1. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B; Houllier A; Meyer D; Girma JP
    Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
    Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
    Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
    Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
    Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T; Sadler JE
    J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the von Willebrand factor A1 domain to histone.
    Ward CM; Tetaz TJ; Andrews RK; Berndt MC
    Thromb Res; 1997 Jun; 86(6):469-77. PubMed ID: 9219327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of von willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanning mutagenesis.
    Matsushita T; Meyer D; Sadler JE
    J Biol Chem; 2000 Apr; 275(15):11044-9. PubMed ID: 10753907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
    Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor.
    Depraetere H; Ajzenberg N; Girma JP; Lacombe C; Meyer D; Deckmyn H; Baruch D
    Blood; 1998 May; 91(10):3792-9. PubMed ID: 9573016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex.
    Shen Y; Romo GM; Dong JF; Schade A; McIntire LV; Kenny D; Whisstock JC; Berndt MC; López JA; Andrews RK
    Blood; 2000 Feb; 95(3):903-10. PubMed ID: 10648402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine sulfation of glycoprotein I(b)alpha. Role of electrostatic interactions in von Willebrand factor binding.
    Dong J; Ye P; Schade AJ; Gao S; Romo GM; Turner NT; McIntire LV; López JA
    J Biol Chem; 2001 May; 276(20):16690-4. PubMed ID: 11279169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
    Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
    Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.
    Vicente V; Houghten RA; Ruggeri ZM
    J Biol Chem; 1990 Jan; 265(1):274-80. PubMed ID: 2104618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
    Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1.
    Peng Y; Berndt MC; Cruz MA; López JA
    Blood; 2004 Dec; 104(13):3971-8. PubMed ID: 15319289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
    Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC
    Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor mediates platelet spreading through glycoprotein Ib and alpha(IIb)beta3 in the presence of botrocetin and ristocetin, respectively.
    McCarty OJ; Calaminus SD; Berndt MC; Machesky LM; Watson SP
    J Thromb Haemost; 2006 Jun; 4(6):1367-78. PubMed ID: 16706984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.